Shareholders have rejected Florenz’s takeover offer, and Bougen is still talking of putting a recapitalisation plan before the board.
After four long, difficult, expensive years since listing on the NZX, Cannasouth reckons it’s reached a turning point.
Saturday’s election result was broadly in line with expectations but a few sectors are primed to prosper under a change of government.
NZ-founded, ASX-listed chemicals group has lost its third director post-IPO.
Initial reaction strongly negative as market digests risks of Australian leaky pipes problem.
Insurance company’s underlying profit expected to be between $7m and $10m, including large events.
In a 90-minute presentation CEO Ross Taylor rebuts claims a faulty product is behind bursting pipes in WA, blaming problems on faulty installation.
Offshore private equity player seems most likely, Sky-watchers suggest, as company stabilises its performance.
Fletcher has placed its shares in trading halt as it prepares a response to an expert report on leaky pipes in Australia – information it appears to have had since June.
Mystery of why the company's share buyback has been paused since May is solved, at least.